Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA rejects Mallinckrodt’s abuse-deterrent form of Roxicodone

pharmatimesDecember 13, 2018

Tag: FDA , Oxycodone , Mallinckrodt

PharmaSources Customer Service